Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs EDOXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs EDOXABAN: Safety Overview

Metric ECULIZUMAB EDOXABAN
Total FAERS Reports 44,190 8,334
Deaths Reported 4,626 992
Death Rate 10.5% 11.9%
Hospitalizations 12,421 4,729
Average Patient Age 42.6 yrs 77.2 yrs
% Female Patients 59.5% 46.5%
FDA Approval Date N/A Jan 8, 2015
Manufacturer Alexion Pharmaceuticals Inc. Daiichi Sankyo Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription